combine@alvar.ug

High Postdischarge Morbidity in Ugandan Children With Severe Malarial Anemia or Cerebral Malaria

High Postdischarge Morbidity in Ugandan Children With Severe Malarial Anemia or Cerebral Malaria

Show simple record

dc.contributor.author Opoka, Robert O.
dc.contributor.author Hamre, Karen E. S.
dc.contributor.author Brand, Nathan
dc.contributor.author Bangirana, Paul
dc.contributor.author Idro, Richard
dc.contributor.author John, Chandy C.
dc.date.accessioned 2021-01-01T21:57:58Z
dc.date.available 2021-01-01T21:57:58Z
dc.date.issued 2017
dc.identifier.issn 2048-7193
dc.identifier.uri http://combine.alvar.ug/handle/1/48093
dc.description.abstract Background. Cerebral malaria (CM) and severe malarial anemia (SMA) account for a substantial proportion of malaria-related deaths in sub-Saharan Africa. However, postdischarge morbidity in children with CM or SMA has not been well established. Methods. Children 18 months to 12 years of age, enrolled on admission to Mulago National Referral Hospital in Kampala, Uganda (CM, n = 162; SMA, n = 138), and healthy children recruited from the community (CC) (n = 133) were followed up for 6 months. The incidences of hospitalizations and outpatient clinic visits for illness during the follow-up period were compared between children with CM or SMA and the CC. Results. After adjustment for age, sex, and nutritional status, children with SMA had a higher incidence rate ratio (IRR) than CC for hospitalization (95% confidence interval [CI], 20.81 [2.48-174.68]), hospitalization with malaria (17.29 [95% CI, 2.02-148.35]), and clinic visits for any illness (95% CI, 2.35 [1.22-4.51]). Adjusted IRRs for children with CM were also increased for all measures compared with those for CC, but they achieved statistical significance only for clinic visits for any illness (2.24 [95% CI, 1.20-4.15]). In both groups, the primary reason for the clinic visits and hospitalizations was malaria. Conclusions. In the 6 months after initial hospitalization, children with SMA have an increased risk of repeated hospitalization, and children with CM or SMA have an increased risk of outpatient illness. Malaria is the main cause of inpatient and outpatient morbidity. Malaria prophylaxis has the potential to decrease postdischarge morbidity rates in children with SMA or CM.]
dc.description.sponsorship National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
dc.description.sponsorship Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R01NS055349, D43 NS078280]
dc.description.sponsorship NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349, R01NS055349] Funding Source: NIH RePORTER
dc.language English
dc.publisher OXFORD UNIV PRESS
dc.relation.ispartof Journal of the Pediatric Infectious Diseases Society
dc.subject Cerebral Malaria
dc.subject Incidence
dc.subject Readmission
dc.subject Severe Malarial Anemia
dc.title High Postdischarge Morbidity in Ugandan Children With Severe Malarial Anemia or Cerebral Malaria
dc.type Article
dc.identifier.isi 000416622700006
dc.identifier.doi 10.1093/jpids/piw060
dc.identifier.pmid 28339598
dc.publisher.city OXFORD
dc.publisher.address GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
dc.identifier.eissn 2048-7207
dc.identifier.volume 6
dc.identifier.issue 3
dc.identifier.spage E41
dc.identifier.epage E48
dc.subject.wc Infectious Diseases
dc.subject.wc Pediatrics
dc.subject.sc Infectious Diseases
dc.subject.sc Pediatrics
dc.description.oa Green Published
dc.description.pages 8
dc.subject.kwp Plasmodium-Falciparum Malaria
dc.subject.kwp Placebo-Controlled Trial
dc.subject.kwp Western Kenya
dc.subject.kwp Mortality
dc.subject.kwp Transfusion
dc.subject.kwp Multicenter
dc.subject.kwp Impairment
dc.subject.kwp Sequelae
dc.description.affiliation Makerere Univ, Dept Paediat, Kampala, Uganda
dc.description.affiliation Makerere Univ, Dept Psychiat, Kampala, Uganda
dc.description.affiliation Univ Minnesota, Div Global Pediat, Minneapolis, MN USA
dc.description.affiliation Columbia Coll Phys & Surg, New York, NY USA
dc.description.affiliation Indiana Univ, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46204 USA
dc.description.email chjohn@iu.edu
dc.description.corr John, CC (corresponding author), Ryan White Ctr Pediat Infect Dis & Global Hlth, 1044 W Walnut St,R4 402D, Indianapolis, IN 44202 USA.
dc.description.orcid Idro, Richard/0000-0003-4728-4605


This record appears in the collections of the following institution(s)

Show simple record

Search Entire Database


Browse

My Account